AZD0530 difumarate - Saracatinib difumarate

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1456

CAS [893428-72-3]

MF C27H32ClN5O5.2C4H4O4
MW 774.17

Purity: 99%
Soluble in DMSO

AZD0530 difumarate

Description

An orally bioavailable tyrosine kinase inhibitor, specifically targeting Src and Abl, those kinases often overexpressed in chronic myeloid leukema cells. Optimal water-soluble form.

Saracatinib (as free base) is available as Axon 3284.

H Laurent et al. N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J. Med. Chem. 2006, 49, 6465.

YM Chang et al. Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene 2008, 1–11.

PM Gwanmesia et al. The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines. BMC Cancer 2009, 9, 53.

TP Green et al. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Molecular Oncology 2009, 3(3), 248-261.

C Dulsat et al. Saracatinib. Drugs Fut. 2009, 34(2), 106.

Inhibitor of SRC and ABL tyrosine kinases

Chemical name

(5-Chloro-benzo[1,3]dioxol-4-yl)-[7-[2-(4-methyl-piperazin-1-yl)-ethoxy]-5-(tetrahydro-pyran-4-yloxy)-quinazolin-4-yl]-amine (2E)-2-butenedioate (1:2)

Parent CAS No.

[379231-04-6]

Order

Size	Unit Price	Stock
5 mg	€70.00	In Stock
25 mg	€200.00	In Stock

Special Offers

Size	Unit Price	Stock
2 x 5 mg	€100.00	In Stock

Need more? Bulk Inquiry

Related Products

Axon ID	Name	Description
1136	SU 6656	SRC kinase inhibitor	€120.00
1392	Dasatinib	Bcr-Abl and Src tyrosine kinase inhibitor	€90.00
1407	SKI 606	Bcr-Abl and Src tyrosine kinase inhibitor	€75.00
1698	A 770041	Orally active src-family selective lck inhibitor	€140.00
1941	MLR 1023	Selective allosteric activator of Lyn kinase	€95.00
2097	CGP 77675	Src Family kinase (SFK) inhibitor	€65.00
1892	1-NM-PP1	Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk)	€95.00
2366	NG 25 trihydrochloride	Type II inhibitor of TAK1 (MAP3K7) and MAP4K2 (GCK)	€75.00
2381	WH-4-023	Orally active src-family selective lck inhibitor	€90.00
2560	Tilfrinib	Brk inhibitor with antiproliferative activity in breast tumor cells	€95.00
2778	Squarunkin A	Selective UNC119–cargo interaction inhibitor	€125.00
3284	Saracatinib	Inhibitor of SRC and ABL tyrosine kinases	€70.00
3099	TL02-59	Potent, selective and orally active Fgr and Lyn inhibitor	€120.00
3973	XL-228	Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC)	Inquire
4010	BLK degrader compound 9	First potent and highly selective monomeric degrader of B-lymphoid tyrosine kinase (BLK)	€180.00

Customer Support

Customer Services

About Axon Medchem

Contact Us

AZD0530 difumarate - Saracatinib difumarate

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Customer Support

Customer Services

About Axon Medchem

Contact Us

AZD0530 difumarate - Saracatinib difumarate

Description

Chemical name

Parent CAS No.

Related Products

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Send us a message

Contact Us